Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 2:22 PM
Ignite Modification Date: 2025-12-25 @ 12:59 PM
NCT ID: NCT02360059
Description: None
Frequency Threshold: 0
Time Frame: Adverse event data collected was up to 18.5 weeks (13.5 weeks of intervention and 4 ± 1week after end of treatment).
Study: NCT02360059
Study Brief: Metformin for Reduction of Paclitaxel-Related Neuropathy in Patients With Breast Cancer
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Metformin Group Participants take 1,000 mg Metformin by mouth twice daily for 12 weeks during Paclitaxel treatment. None None 0 1 0 1 View
Placebo Group Participants take placebo by mouth twice daily starting 12 days before, and 12 weeks during Paclitaxel treatment. None None 0 0 0 0 View
Serious Events(If Any):
Other Events(If Any):